cyrus vincent
Aug 14, 2017

Patent Battle Over Breast Cancer Drug: Roche Withdraws Its SLP Against Delhi High Court’s Approval To Biosimilars

Swiss Pharma major, Roche has withdrawn its Special Leave Petition filed in the Supreme Court against the Delhi High Court’s March 3 decision, rejecting its challenge to the grant of approval to drug companies, Biocon and Mylan, to use product data for Transtuzumab, a generic biosimilar for cancer.

http://bit.ly/2wKnEGu